norcantharidin has been researched along with Cirrhosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Tang, C; Wen, L; Xiao, Z; Yin, D; Zeng, D; Zhou, X | 1 |
| Li, Y; Luo, H; Shan, Y; Tang, C; Tian, J; Wei, J; Wen, L; Xiao, Z; Xu, Q; Zeng, D | 1 |
| Chen, X; Fang, X; Li, Y; Shan, Y; Tang, C; Tao, Y; Tian, J; Wei, J; Xiao, Z; Zeng, D | 1 |
| Li, J; Li, Y; Liao, Y; Liu, H; Luo, H; Sun, L; Tang, C; Xiao, H; Xiao, Z; Zeng, D | 1 |
| Duan, S; Hou, T; Li, H; Li, J; Li, Y; Liu, F; Liu, H; Liu, Y; Peng, Y; Sun, L; Sun, Y; Wang, M; Wang, S; Xi, Y; Xiao, L; You, Y | 1 |
| Chen, Q; Duan, SB; Hou, T; Li, J; Li, Y; Ling, GH; Liu, FY; Luo, JH; Peng, YM; Sun, L | 1 |
| Chen, Q; Ge, Y; Li, J; Li, Y; Liu, FY; Peng, YM; Sun, L; Sun, Y; Ye, K | 1 |
| Duan, SB; Li, J; Li, Y; Ling, GH; Liu, FY; Liu, YH; Peng, YM; Xu, XQ; Ye, K; Zhou, LT | 1 |
1 review(s) available for norcantharidin and Cirrhosis
| Article | Year |
|---|---|
Norcantharidin, a protective therapeutic agent in renal tubulointerstitial fibrosis.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Fibrosis; Humans; Kidney Diseases; Kidney Tubules; NF-kappa B; Phosphoprotein Phosphatases; Signal Transduction | 2012 |
7 other study(ies) available for norcantharidin and Cirrhosis
| Article | Year |
|---|---|
Protein Phosphatase 2A Inhibiting β-Catenin Phosphorylation Contributes Critically to the Anti-renal Interstitial Fibrotic Effect of Norcantharidin.
Topics: Animals; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Enzyme Inhibitors; Fibrosis; Humans; Kidney Tubules, Proximal; Male; Nephritis, Interstitial; Phosphorylation; Protein Phosphatase 2; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2020 |
Norcantharidin protects against renal interstitial fibrosis by suppressing TWEAK-mediated Smad3 phosphorylation.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Collagen Type I; Cytokine TWEAK; Fibronectins; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Phosphorylation; Protective Agents; Smad3 Protein; Transforming Growth Factor beta1; Ureteral Obstruction | 2020 |
NCTD Prevents Renal Interstitial Fibrosis via Targeting Sp1/lncRNA Gm26669 Axis.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Drug Delivery Systems; Epithelial Cells; Fibrosis; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation; Kidney; Kidney Tubules, Proximal; Lentivirus; Male; Mice; Mice, Inbred C57BL; Nephritis, Interstitial; Real-Time Polymerase Chain Reaction; RNA, Long Noncoding; Sp1 Transcription Factor; Transfection; Transforming Growth Factor beta1 | 2021 |
RNA-Seq analysis of potential lncRNAs and genes for the anti-renal fibrotic effect of norcantharidin.
Topics: Animals; Apoptosis; Biomarkers; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Cells, Cultured; Fibrosis; Gene Expression Regulation; Gene Regulatory Networks; Mice; Mice, Inbred C57BL; RNA-Seq; RNA, Long Noncoding; Ureteral Obstruction | 2019 |
Norcantharidin inhibits renal interstitial fibrosis by blocking the tubular epithelial-mesenchymal transition.
Topics: Actins; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cadherins; Cell Line; Epithelial-Mesenchymal Transition; Fibrosis; Gene Expression Regulation; Humans; Kidney Tubules; Male; Phenotype; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Smad3 Protein; Snail Family Transcription Factors; Transcription Factors; Transforming Growth Factor beta1; Ureteral Obstruction | 2013 |
Norcantharidin attenuates tubulointerstitial fibrosis in rat models with diabetic nephropathy.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Calcineurin; Collagen Type IV; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Fibronectins; Fibrosis; Kidney; Male; Nephritis, Interstitial; Proteinuria; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1 | 2011 |
Norcantharidin ameliorates proteinuria, associated tubulointerstitial inflammation and fibrosis in protein overload nephropathy.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Connective Tissue Growth Factor; Fibrosis; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Male; Nephritis, Interstitial; NF-kappa B; Proteinuria; Rats; Rats, Sprague-Dawley | 2008 |